ArticleBMC health services research2023

Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China.

Wanyi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.